This third-quarter report arrives at an important inflection point for MNTK. After a comparatively soft 2025, revenue growth has reaccelerated, with second-quarter 2026 revenue climbing 19.7% year over year. Because the company self-markets much of its environmental attributes, profitability swings meaningfully with RIN prices and with management's decisions on when to sell them. The Turkey, North Carolina facility began generating power in July 2026, making this the first report to capture early contributions from that ramp-up. With 2026 guidance reaffirmed, investors are watching for evidence that the company's improving trajectory is durable rather than driven by one-off factors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Analysts expect MNTK to post third-quarter earnings of $0.05 per share on revenue of $53.34 million, according to consensus estimates. That would compare with $0.04 per share and $45.26 million in the prior-year period, implying expected revenue growth of roughly 18%.
Beyond the headline figures, investors will scrutinize operating metrics. RNG production is typically measured in MMBtu (million British thermal units), while renewable electricity output is measured in MWh (megawatt-hours). RIN pricing remains central: management has said it committed to selling the majority of expected third-quarter RINs at an average of about $2.66, above the July 2026 D3 index price of $2.64. Adjusted EBITDA will also be closely watched after it surged 144.5% year over year in the second quarter to $12.3 million.
Historically, MNTK shares have produced above-average swings around earnings, reflecting sensitivity to RIN prices, production volumes, and regulatory developments in the renewable fuels market.
Sentiment heading into this report is cautiously optimistic. Montauk's second-quarter results showed a clear return to top-line growth, and the company's disclosed RIN sale commitments suggest management locked in pricing above recent index levels—a potentially supportive signal for the quarter's environmental attribute revenue.
Still, the stock has historically moved sharply around earnings, and key risks remain. RIN prices and renewable fuel credit markets can be volatile, and regulatory developments—particularly around North Carolina's Clean Energy Portfolio Standard and swine RECs (Renewable Energy Certificates)—can shift demand. The pace of the Turkey facility's production ramp and any updates on project costs will also shape how investors interpret the quarter.
The most important item after the release will be whether management reaffirms or adjusts its full-year 2026 guidance. The company has previously guided to RNG production of 5.8–6.0 million MMBtu, RNG revenue of $175–$190 million, and renewable electricity production of 195,000–207,000 MWh with revenue of $33–$37 million. Any change to these ranges would be a meaningful signal.
Investors should also track the Turkey, North Carolina ramp-up. Management has indicated it expects production volumes to increase through the second half of 2026 as additional feedstock collection comes online, with the first phase of the project carrying an unchanged capital investment expectation of roughly $200 million.
Finally, watch RIN pricing and sales strategy. Because Montauk self-markets a large share of its RINs, the timing and realized price of these sales can materially affect quarterly results. Regulatory outcomes and broader renewable fuels market conditions will continue to influence both revenue and sentiment in the quarters ahead. From what I see, this is important because it ties directly into the durability of the growth story.
In preparing for earnings season, I often turn to Tickeron's AI Screener to quickly filter renewable energy names and compare technical and fundamental setups across the sector. It helps surface patterns and performance metrics that might otherwise take hours to review manually, giving a clearer sense of where MNTK stands relative to peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MNTK moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on MNTK as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for MNTK just turned positive on November 02, 2026. Looking at past instances where MNTK's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.
Following a +10.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 154 of 176 cases where MNTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
MNTK broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. MNTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.431) is normal, around the industry mean (2.450). P/E Ratio (53.200) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ChemicalsSpecialty